Dr. Ryan J. Sullivan on Frontline Immunotherapy Sequencing in Melanoma

Leggi l'articolo originale


Cancer Network spoke with Ryan J. Sullivan, MD, of Massachusetts General Hospital, about the debate between immunotherapy sequencing vs targeted therapy for melanoma.

Lascia un commento